Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Boehringer Ingelheim
McKesson
Johnson and Johnson
Harvard Business School

Last Updated: November 12, 2019

DrugPatentWatch Database Preview

Litigation Details for MERCK FROSST CANADA & CO. v. MYLAN PHARMACEUTICALS INC. (D.N.J. 2011)

See Plans and Pricing

« Back to Dashboard

MERCK FROSST CANADA & CO. v. MYLAN PHARMACEUTICALS INC. (D.N.J. 2011)

Docket   Start Trial Date Filed 2011-12-29
Court District Court, D. New Jersey Date Terminated 2012-04-16
Cause 15:1126 Patent Infringement Assigned To Freda L. Wolfson
Jury Demand None Referred To Lois H. Goodman
Parties MERCK CANADA INC.; MERCK FROSST CANADA & CO.; MERCK SHARP & DOHME PHARMACEUTICALS; MYLAN PHARMACEUTICALS INC.
Patents 8,007,830
Attorneys ARNOLD B. CALMANN; JEFFREY S. SOOS; JEFFREY Z.Y. LIAO; RITA DARLENE TURNER; SHEILA F. MCSHANE; VINNY LEE
Link to Docket External link to docket
Small Molecule Drugs cited in MERCK FROSST CANADA & CO. v. MYLAN PHARMACEUTICALS INC.
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for MERCK FROSST CANADA & CO. v. MYLAN PHARMACEUTICALS INC. (D.N.J. 2011)

Date Filed Document No. Description Snippet Link To Document
2011-12-29 1 right, title, and interest in U.S. Patent No. 8,007,830 (the “‘830 patent”), which is attached as Exhibit…the ‘830 patent to the FDA in connection with its NDA No. 021409, identifying it as a patent “With respect…prior to the expiration of the ‘830 patent would infringe the ‘830 patent under 35 U.S.C. §§ 271(a), (b) and…with respect to the ‘830 patent constituted an act of infringement of that patent 25. This case is an exceptional…Defendant. CIVIL ACTION NG.: COMPLAINT FOR PATENT INFRINGEMENT #1739216 V'I 105686-78457 Case External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Mallinckrodt
Dow
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.